Herpesvirus lytic replication and the cell cycle: Arresting new developments

Journal of Virology

Volumn 75, Issue 10, 2001, Pages 4475-4481

  Flemington, E K ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR E2F;

CELL CYCLE; CYTOMEGALOVIRUS; DNA SYNTHESIS; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; HERPES SIMPLEX VIRUS; HUMAN; IMMEDIATE EARLY GENE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANIMALS; CELL CYCLE; CYTOMEGALOVIRUS; HERPESVIRIDAE; HERPESVIRUS 4, HUMAN; HUMANS; SIMPLEXVIRUS; VIRUS REPLICATION;

EID: 0035031922     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.10.4475-4481.2001     Document Type: Short Survey

References (50)

1. Induction of cellular DNA synthesis and increased mitotic activity in Syrian hamster embryo cells abortively infected with human cytomegalovirus
2. Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on differentiation of epithelial cells in oral hairy leukoplakia
3. Activation of proto-oncogenes: An immediate early event in human cytomegalovirus infection
4. Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus
5. 1 checkpoint function
6. The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein
7. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication
8. 1
9. A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1
10. Role of human cytomegalovirus immediate-early proteins in cell growth control
11. 1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors
12. 1 growth arrest mediated by a region encompassing the bZIP domain of the Epstein-Barr virus transactivator Zta
13. Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency
14. The effects of herpes simplex virus type I L-particles on virus entry, replication, and the infectivity of naked herpesvirus DNA
15. Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein
16. 1/S transition
17. 1 entry in quiescent cells
18. Inhibition of cell growth and Epstein-Barr virus reactivation by CD40 stimulation in Epstein-Barr virus-transformed B cells
19. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein
20. 1 phase of the cell cycle
21. Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0
22. Analysis of cyclin-dependent kinase activity after herpes simplex virus type 2 infection
23. Cytomegalovirus infection induces high levels of cyclins, phosphorylated RB, and p53, leading to cell cycle arrest
24. Transactivation of herpes simplex virus type 1 immediate-early gene expression by virion-associated factors is blocked by an inhibitor of cyclin-dependent protein kinases
25. Differential effects of TPA on cell growth and Epstein-Barr virus reactivation in epithelial cell lines derived from gastric tissues and B cell line Raji
26. Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus
27. Herpes simplex virus 1 a regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3
28. 1 into S phase of the cell cycle
29. 1 to S
30. 1 phase of the cell cycle
31. Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts
32. The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells
33. Herpes simplex virus induces intracellular redistribution of E2F4 and accumulation of E2F pocket protein complexes
34. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter
35. Induction of herpes simplex virus type 1 immediate-early gene expression by a cellular activity expressed in Vero and NB41A3 cells after growth arrest release
36. Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta
37. Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents
38. Cell cycle dysregulation by human cytomegalovirus: Influence of the cell cycle phase at the time of infection and effects on cyclin transcription
39. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription
40. 1 into early S phase in terminally differentiated cells
41. 1 phase of the cell cycle
42. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis
43. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction
44. A single amino acid substitution in the cyclin D binding domain of the infected cell protein no. 0 abrogates the neuroinvasiveness of herpes simplex virus without affecting its ability to replicate
45. 1
46. Persistence of Epstein-Barr virus in the parotid gland
47. Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1
48. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia
49. The Epstein-Bart virus immediate -early gene product, BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle
50. Functional and physical interaction between p53 and BZLFI: Implications for Epstein-Barr virus latency